BioCentury | May 25, 2015
Clinical News

RenaSure: Clinical trial started

...CareDx began the U.S. clinical DART trial of RenaSure in de novo kidney transplant patients. The...
...first stage will enroll 200 patients, and the second stage will establish clinical utility of RenaSure...
...laboratory test to be performed at a CLIA-certified lab. CareDx Inc. (NASDAQ:CDNA), Brisbane, Calif. Product: RenaSure...
Items per page:
1 - 1 of 1